Remove 2022 Remove Pharmaceutical products Remove Physicians Remove Safety
article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

August 23, 2022. The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. PharmaKinnex has spent more than 18 years helping companies adopt new strategies, increase profitability, and expand their product reach. More convenience and safety?

Pharma 52
article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

Second, the production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic (usually transplant) departments. 10 Benefits of point-of-care CAR T-cell therapy Even after validation of the efficacy and safety of the therapy, two critical challenges remained – affordability and accessibility.

article thumbnail

The imperative of fridge-free vaccines

European Pharmaceutical Review

Over his career as a physician and scientist he published 108 papers and 49 patents. TRS 953 – Annex 2, Appendix 1: Stability testing of active pharmaceutical ingredients and finished pharmaceutical products: Stability conditions for WHO Member States by Region. Injection Safety Fact Sheet. Internet] Burak.